Rock Creek Pharmaceuticals, Inc. (NASDAQ:STSI)

CAPS Rating: 1 out of 5

The Company is engaged in developing, implementing and licensing scientific technology for the curing of tobacco and also manufactures, markets and develops very low-nitrosamine smokeless tobacco products and selling of discount cigarettes.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 10/24/2013 3:24:50 PM : Underperform Start Price: $1.90 STSI Score: +6.79

DOG falling off the cliff

Featured Broker Partners


Advertisement